Properties
Description
BGB-102 is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells.
Molecular Formula
C22H25BrN4O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
BGB-102 is used in studies as an EGFR-HER2 inhibitor, helping to elucidate its effects on tumor growth and potential for targeted cancer therapy.